Clinical trial · Interventional
Screening for Lung Cancer in Current or Past Smokers With Chronic Obstructive Pulmonary Disease
A Randomised Controlled Trial of Surveillance for the Early Detection of Lung Cancer in an at Risk Group [Lung-SEARCH Trial]
NCT00512746CI-TRIAL-00005963completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
RATIONALE: Screening tests or exams may help doctors find lung cancer sooner, when it may be easier to treat. PURPOSE: This randomized clinical trial is studying screening tests or exams to see how well they work compared to usual care in finding early stage lung cancer in current or past smokers with chronic obstructive pulmonary disease.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Lung Cancer | Malignant Lung Neoplasm | CURATED_EXACT | 0.92 |
| Precancerous Condition | — | UNRESOLVED | — |
Interventions
Interventions (4)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Autofluorescence bronchoscopy | Procedure | — | UNRESOLVED |
| Chest x ray | Other | — | UNRESOLVED |
| CT scan | Procedure | — | UNRESOLVED |
| cytology and cytometry specimen collection procedure | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- OTHER
- label
- Surveillance
- description
- Screened arm
- interventionNames
- Other: cytology and cytometry specimen collection procedure
- Other: Chest x ray
- Procedure: Autofluorescence bronchoscopy
- Procedure: CT scan
- type
- ACTIVE_COMPARATOR
- label
- Control
- description
- Control arm
- interventionNames
- Other: Chest x ray
Primary outcomes (1)
- measure
- Proportion of lung cancer that is diagnosed as stage I or II
- timeFrame
Eligibility
Eligibility (as posted)
- Sex
- All
Show eligibility criteria text
DISEASE CHARACTERISTICS: Inclusion criteria: * Meets 1 of the following criteria: * Current smoker, defined as ≥ a 20 pack year smoking history and/or 20 year duration of smoking * Ex-smoker who has quit smoking within the past 8 years AND has ≥ a 20 pack year smoking history and/or 20 year duration of smoking * Mild to moderate chronic obstructive pulmonary disease (COPD) as defined by the GOLD criteria * Mild COPD: FEV\_1/forced vital capacity (FVC) \< 70%; FEV\_1 ≥ 80% of predicted\* * Moderate COPD: FEV\_1/FVC \< 70%; FEV\_1 50-80% of predicted\* NOTE: \*Spirometric values will be obtained post bronchodilator according to the recommendations in the GOLD criteria Exclusion criteria: * Inadequate lung function (FEV\_1 \< 50% of predicted after bronchodilator) PATIENT CHARACTERISTICS: Inclusion criteria: * Life expectancy must be at least 5 years Exclusion criteria: * History of malignant disease within the past 5 years except non-melanomatous skin cancers * Other serious co-morbidity * Evidence of severe or uncontrolled systemic diseases that, in the view of the investigator, makes it undesirable for the patient to participate in this trial * Any disorder making reliable informed consent impossible * Unlikely to co-operate with a 5 year follow-up PRIOR CONCURRENT THERAPY: * Patients may receive all concurrent therapy deemed to provide adequate care as decided by their medical doctors
References
Publications (1)
- DERIVEDSpiro SG, Hackshaw A; LungSEARCH Collaborative Group. Research in progress--LungSEARCH: a randomised controlled trial of surveillance for the early detection of lung cancer in a high-risk group. Thorax. 2016 Jan;71(1):91-3. doi: 10.1136/thoraxjnl-2015-207433. Epub 2015 Jul 2. PMID 26138736